Overview

Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This is a blinded cross-over study to see if extended wear insulin infusion sets can prolong insulin infusion set wear up to 7 days in adults with Type 1 Diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
Stanford University
Collaborator:
Medtronic
Treatments:
Heparin